Returned drug products shall be identified as such and held. If conditions under which they have been held, stored, or shipped are such that quality, safety or effectiveness may have been impaired, they shall be destroyed.
The graph holds this control, the 0 it maps to, and the evidence behind each claim, over MCP and REST.